Midazolam Suppliers & Bulk Manufacturers
Available Forms: Intravenous (IV), Intramuscular (IM), and Intranasal Injection
Available Strengths: 1 mg/mL, 5 mg/mL
Reference Brands: Versed(US);
Category:
Critical Care
Midazolam is a fast-acting benzodiazepine for sedation, seizures, and anesthesia, available in 1 mg/mL and 5 mg/mL injections and 2 mg/mL oral syrup. Brands include Versed, Buccolam, and Midazolam B. Braun. It is widely sourced via pharma B2B platforms for hospitals, ICUs, and emergency medical services.
Midazolam is available in Intravenous (IV), Intramuscular (IM), and Intranasal Injection
and strengths such as 1 mg/mL, 5 mg/mL.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Midazolam is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Midazolam can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Midazolam is a short-acting benzodiazepine used for procedural sedation, anesthesia induction, seizures, and ICU sedation. Available in injectable forms (1 mg/mL, 5 mg/mL), oral syrup (2 mg/mL), and buccal/rectal solutions, it is supplied in ampoules, vials, and pre-filled syringes. US brands include Versed and generics from Pfizer and Fresenius, while the EU markets Buccolam (buccal), Midazolam Accord, and B. Braun formulations. Midazolam’s rapid onset and versatility make it essential in hospitals, ambulatory centers, and emergency care. Pharma B2B platforms regularly supply Midazolam to healthcare institutions through streamlined procurement channels for anesthesia and critical care needs.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing